{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:12Z","timestamp":1761919752064},"reference-count":13,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":732,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1111\/ane.12182","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T06:59:02Z","timestamp":1377845942000},"page":"e12-e15","source":"Crossref","is-referenced-by-count":18,"title":["Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?"],"prefix":"10.1155","volume":"129","author":[{"given":"P.","family":"Wipfler","sequence":"first","affiliation":[{"name":"Department of Neurology; Christian-Doppler-Klinik; Paracelsus Medical University; Salzburg Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Harrer","sequence":"additional","affiliation":[{"name":"Department of Neurology; Christian-Doppler-Klinik; Paracelsus Medical University; Salzburg Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pilz","sequence":"additional","affiliation":[{"name":"Department of Neurology; Christian-Doppler-Klinik; Paracelsus Medical University; Salzburg Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Oppermann","sequence":"additional","affiliation":[{"name":"Department of Neurology; Christian-Doppler-Klinik; Paracelsus Medical University; Salzburg Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Afazel","sequence":"additional","affiliation":[{"name":"Central Laboratory; Christian-Doppler-Klinik; Paracelsus Medical University; Salzburg Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Haschke-Becher","sequence":"additional","affiliation":[{"name":"Central Laboratory; Christian-Doppler-Klinik; Paracelsus Medical University; Salzburg Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sellner","sequence":"additional","affiliation":[{"name":"Department of Neurology; Christian-Doppler-Klinik; Paracelsus Medical University; Salzburg Austria"},{"name":"Department of Neurology; Klinikum rechts der Isar; Technische Universit\u00e4t M\u00fcnchen; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Trinka","sequence":"additional","affiliation":[{"name":"Department of Neurology; Christian-Doppler-Klinik; Paracelsus Medical University; Salzburg Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kraus","sequence":"additional","affiliation":[{"name":"Department of Neurology; Christian-Doppler-Klinik; Paracelsus Medical University; Salzburg Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"10.1111\/ane.12182-BIB0001|ane12182-cit-0001","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/ane.12182-BIB0002|ane12182-cit-0002","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa052643","article-title":"Oral fingolimod (FTY720) for relapsing multiple sclerosis","volume":"355","author":"Kappos","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/ane.12182-BIB0003|ane12182-cit-0003","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","article-title":"Anti-JC virus antibodies: implications for PML risk stratification","volume":"68","author":"Gorelik","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12182-BIB0004|ane12182-cit-0004","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.0b013e31821e7c8a","article-title":"Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis","volume":"76","author":"O'Connor","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12182-BIB0005|ane12182-cit-0005","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-012-6808-8","article-title":"Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis","volume":"260","author":"Havla","year":"2013","journal-title":"J Neurol"},{"key":"10.1111\/ane.12182-BIB0006|ane12182-cit-0006","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12182-BIB0007|ane12182-cit-0007","doi-asserted-by":"crossref","first-page":"e31784","DOI":"10.1371\/journal.pone.0031784","article-title":"Lymphocyte subsets show different response patterns to in vivo bound natalizumab-a flow cytometric study on patients with multiple sclerosis","volume":"7","author":"Harrer","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/ane.12182-BIB0008|ane12182-cit-0008","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1177\/1352458512458009","article-title":"Severe multiple sclerosis reactivation under fingolimod 3\u00a0months after natalizumab withdrawal","volume":"18","author":"Daelman","year":"2012","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12182-BIB0009|ane12182-cit-0009","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1177\/1352458512468498","article-title":"Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption","volume":"19","author":"Laroni","year":"2013","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12182-BIB0010|ane12182-cit-0010","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1177\/1352458512464282","article-title":"Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings","volume":"18","author":"Rinaldi","year":"2012","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12182-BIB0011|ane12182-cit-0011","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/ane.12082","article-title":"Switching from natalizumab to fingolimod: an observational study","volume":"128","author":"Sempere","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12182-BIB0012|ane12182-cit-0012","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/1352458511431073","article-title":"Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped","volume":"18","author":"Rispens","year":"2012","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12182-BIB0013|ane12182-cit-0013","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1177\/1352458512464283","article-title":"Time to talk about timing-when to start, stop and change anti-migratory drugs in MS","volume":"18","author":"St\u00fcve","year":"2012","journal-title":"Mult Scler"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12182","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12182\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:47:00Z","timestamp":1671540420000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12182","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}